A Comprehensive Management System for Heart Failure Improves Clinical Outcomes and Reduces Medical Resource Utilization
- 1 January 1997
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 79 (1), 58-63
- https://doi.org/10.1016/s0002-9149(96)00676-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Perspective of the pharmaceutical industry on the development of new drugs for heart failureJournal of the American College of Cardiology, 1993
- Natural history and patterns of current practice in heart failureJournal of the American College of Cardiology, 1993
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Prevalence and mortality rate of congestive heart failure in the United StatesJournal of the American College of Cardiology, 1992
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure studyThe American Journal of Cardiology, 1991
- Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalenceArchives of Internal Medicine, 1990
- Functional Status and Well-being of Patients With Chronic ConditionsJama-Journal Of The American Medical Association, 1989